Supreme Petrochem vs Chemplast Sanmar business model compares concentrated polystyrene and styrenic polymer manufacturing against chlor-alkali chemicals and specialty PVC resin manufacturing to see which petrochemicals has better business model.

Akums Drugs and Pharmaceuticals vs Suven Pharmaceuticals (Cohance) growth compares concentrated domestic contract manufacturing for branded generics against concentrated specialty pharma intermediate and CDMO manufacturing to see which pharma manufacturing has better growth.

Morarka Finance Q1 results FY27: net profit jumps 171.9% to Rs 0.38 crore as revenue nearly doubles, though absolute figures remain modest for the microcap NBFC. Shares up 4.12% as of 22 July 2026.

Hatsun Agro Q1 results FY27: net profit falls 9.7% to Rs 133 crore despite 21.9% revenue growth, as rising milk procurement costs squeeze margins. Shares trading down 2.67% as of 22 July 2026.

DCM Shriram vs UPL business model compares diversified conglomerate spanning sugar, chlor-alkali chemicals and fertiliser against global agrochemical manufacturing and distribution with worldwide export reach to see which agri-chemicals has better business model.

Anthem Biosciences Q1 results FY27: net profit falls 11.7% to Rs 119 crore as revenue declines 22.6%, a mixed quarter for the CRDMO company. Shares trading down 2.93% as of 22 July 2026.

Gujarat Cotex Q1 results FY27: net profit falls 59.7% to Rs 0.16 crore despite 31% revenue growth, with margin compression the key story. Shares roughly flat as of 22 July 2026.

Sagility Q1 results FY27: net profit soars 45.9% to Rs 216 crore with growth accelerating from revenue to profit, a broad based beat. Shares trading roughly flat as of 22 July 2026.

Adani Total Gas Q1 results FY27: net profit falls 14.5% to Rs 141.72 crore as Brent-linked gas costs surge amid the West Asia crisis, despite 27.27% revenue growth and 13% volume growth. Shares down 0.63% as of 22 July 2026.

GIC Re vs Star Health and Allied Insurance growth compares PSU reinsurance underwriting risk transferred from primary insurers against concentrated private health insurance underwriting to see which insurance has better growth.